Male breast cancer is an uncommon disease, representing <1% of all breast cancer diagnoses. The prognostic factors and expression of molecular markers in male breast carcinomas are similar to female cancer. Cancer stem cell (CSC)s have been associated with tumor aggressiveness and drug resistance. CSCs are characterized by CD44 and/or ALDH1 expression. We investigated their expression in male breast cancer.
Recommended CitationGong, MD, Ping and Palazzo, MD, Juan P., "Expression of Cancer Stem Cell Biomarkers in Male Breast Cancer" (2011). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 64.